Ribociclib (LEE011) Rollover Study for Continued Access
Novartis
Novartis
Novartis
Eli Lilly and Company
Teclison Ltd.
Curis, Inc.
Pfizer
SkinJect, Inc.
Miltenyi Biomedicine GmbH
Incyte Corporation
Ipsen
AstraZeneca
Amgen
Pfizer
Hoffmann-La Roche
Teclison Ltd.
BeOne Medicines
InSightec
Hoffmann-La Roche
Pfizer
InSightec
AstraZeneca
Dren Bio
Recursion Pharmaceuticals Inc.
Jazz Pharmaceuticals
Bayer
AstraZeneca
AstraZeneca
Novartis
Deciphera Pharmaceuticals, LLC
Merck Sharp & Dohme LLC
Pfizer
BeOne Medicines
Gilead Sciences
Pfizer
Alexion Pharmaceuticals, Inc.
Miltenyi Biomedicine GmbH
Boston Scientific Corporation
AstraZeneca
Suzhou Suncadia Biopharmaceuticals Co., Ltd.
Hoffmann-La Roche
AstraZeneca
BeOne Medicines
Pfizer
BeOne Medicines
Hangzhou Hanx Biopharmaceuticals, Ltd.
Merck Sharp & Dohme LLC
AstraZeneca
Novartis
Novartis
Merck Sharp & Dohme LLC